Lataa...
MEDU-31. GSK-3 PROMOTES PROLIFERATION DURING POSTNATAL CEREBELLAR DEVELOPMENT AND MAY BE TARGETED IN MEDULLOBLASTOMA THERAPY
We examined the role of the multi-pathway regulator GSK-3 in medulloblastoma pathogenesis in light of prior studies showing that GSK-3 restricts the proliferation of cerebral neural progenitors, preventing overgrowth. Importantly, GSK-3 regulates diverse intracellular processes, including signaling...
Tallennettuna:
| Julkaisussa: | Neuro Oncol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475151/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.181 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|